Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Variable Doses of Metronidazole for Helicobacter pylori Eradication
IRCT20211012052740N1Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of metronidazole in Helicobacter pylori infection, sponsored by Urmia University of Medical Sciences. Started Dec 2021; status: completed.
02
Drugs
metronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT20211012052740N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211012052740N1.